These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10963134)

  • 1. Fos family members: regulation, structure and role in oncogenic transformation.
    Tulchinsky E
    Histol Histopathol; 2000 Jul; 15(3):921-8. PubMed ID: 10963134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated expression of the serum responsive T1 gene in ras transformed fibroblasts due to the inhibition of c-fos gene activity.
    Kessler R; Zacharova-Albinger A; Laursen NB; Kalousek M; Klemenz R
    Oncogene; 1999 Mar; 18(9):1733-44. PubMed ID: 10208434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials.
    Andersen H; Mahmood S; Tkach V; Cohn M; Kustikova O; Grigorian M; Berezin V; Bock E; Lukanidin E; Tulchinsky E
    Oncogene; 2002 Jul; 21(31):4843-8. PubMed ID: 12101423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
    Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
    Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
    Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JunD mutants with spontaneously acquired transforming potential have enhanced transactivating activity in combination with Fra-2.
    Kameda T; Akahori A; Sonobe MH; Suzuki T; Endo T; Iba H
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9369-73. PubMed ID: 8415709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation.
    McCabe LR; Banerjee C; Kundu R; Harrison RJ; Dobner PR; Stein JL; Lian JB; Stein GS
    Endocrinology; 1996 Oct; 137(10):4398-408. PubMed ID: 8828501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron.
    Bergers G; Graninger P; Braselmann S; Wrighton C; Busslinger M
    Mol Cell Biol; 1995 Jul; 15(7):3748-58. PubMed ID: 7791782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Fos-related antigen-1 in head and neck squamous cell carcinoma.
    Mangone FR; Brentani MM; Nonogaki S; Begnami MD; Campos AH; Walder F; Carvalho MB; Soares FA; Torloni H; Kowalski LP; Federico MH
    Int J Exp Pathol; 2005 Aug; 86(4):205-12. PubMed ID: 16045542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
    Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
    Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1.
    Ito E; Sweterlitsch LA; Tran PB; Rauscher FJ; Narayanan R
    Oncogene; 1990 Dec; 5(12):1755-60. PubMed ID: 2178237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of AP-1 function in cellular transformation pathways.
    Suzuki T; Murakami M; Onai N; Fukuda E; Hashimoto Y; Sonobe MH; Kameda T; Ichinose M; Miki K; Iba H
    J Virol; 1994 Jun; 68(6):3527-35. PubMed ID: 8189491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation.
    Matsuo K; Owens JM; Tonko M; Elliott C; Chambers TJ; Wagner EF
    Nat Genet; 2000 Feb; 24(2):184-7. PubMed ID: 10655067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. fosB is a transforming gene encoding a transcriptional activator.
    Schuermann M; Jooss K; Müller R
    Oncogene; 1991 Apr; 6(4):567-76. PubMed ID: 1903195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility.
    Tkach V; Tulchinsky E; Lukanidin E; Vinson C; Bock E; Berezin V
    Oncogene; 2003 Aug; 22(32):5045-54. PubMed ID: 12902987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of the fos and jun family members c-fos, fosB, Fra-1, Fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation.
    Welter JF; Eckert RL
    Oncogene; 1995 Dec; 11(12):2681-7. PubMed ID: 8545126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity.
    Gruda MC; Kovary K; Metz R; Bravo R
    Oncogene; 1994 Sep; 9(9):2537-47. PubMed ID: 8058317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Fra-2 in cancer.
    Rampioni Vinciguerra GL; Capece M; Scafetta G; Rentsch S; Vecchione A; Lovat F; Croce CM
    Cell Death Differ; 2024 Feb; 31(2):136-149. PubMed ID: 38104183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.